Woodline Partners’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.23M | Sell |
|
|||||
|
2025
Q2 | $18.1M | Buy |
|
|||||
|
2025
Q1 | $4.9M | Buy |
|
|||||
|
2024
Q4 | $491K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $14.8M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $19.9M | Buy |
|
|||||
|
2023
Q1 | $8.11M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $6.47M | Buy |
|
|||||
|
2022
Q2 | $3.66M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $9.71M | Sell |
|
|||||
|
2021
Q3 | $9.78M | Sell |
|
|||||
|
2021
Q2 | $16.2M | Buy |
|
|||||
|
2021
Q1 | $10.1M | Buy |
|
|||||
|
2020
Q4 | $2.72M | Sell |
|
|||||
|
2020
Q3 | $13.5M | Buy |
|
|||||
|
2020
Q2 | $2.98M | Buy |
|